Receptor Agonist/ Antagonist

Receptors are transmembrane proteins that enable the transfer of chemical signals from the cellular outer microenvironment into the cells, as well as within the cell. An agonist is a mimetic of the natural ligand and produces a similar biological effect as the natural ligand when it binds to the receptor. Agonists bind to the receptor at the same binding site as the natural ligand, and results in either a full (conventional agonists) or partial (partial agonists) activation. Receptor antagonists are inhibitors of receptor activity. Antagonists mimic ligands that bind to a receptor and prevent receptor activation by a natural ligand. Preventing activation may have many effects. Where subtypes of receptors occur, it is possible that a single ligand can have agonist and antagonist properties (i.e. mixed pharmacology). Some of the best illustrations of this occur in opioid receptors of which there are three classical subtypes: μ, δ and κ. For example, pentazocine is an antagonist at μ and an agonist at δ/κ opioid receptors

  • G-protein-coupled receptors
  • Ligand-gated ion channels
  • Tyrosine kinase-coupled
  • Drug–receptor interaction

Related Conference of Receptor Agonist/ Antagonist

February 25-26, 2026

16th International Conference on Chemistry Meeting

Paris, France
February 26-27, 2026

29th World Congress on Materials Chemistry

Paris, France
June 17-18, 2026

15th World Congress on Chromatography

Paris, France
August 11-12, 2026

5th World Congress on Plasma Chemistry and Plasma Processing

Amsterdam, Netherlands
September 14-15, 2026

22nd European Organic Chemistry Congress

Rome, Italy
September 21-22, 2026

16th International Chemistry Congress

Barcelona, Spain
November 26-27, 2026

6th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands

Receptor Agonist/ Antagonist Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in